SCHEMBL9315765

SCHEMBL9315765

CCOC(=O)CC(C[N+](=O)[O-])c1cc2cc(C)ccc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 3/20 0.41
TAS1R1 Q7RTX1 3/20 0.41
THRB P10828 2/20 0.41
TP53 P04637 1/20 0.41
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MMP2 P08253 2/20 0.38
ADAM17 P78536 2/20 0.38
MAOB P27338 7/20 0.37
MAOA P21397 2/20 0.37
CA12 O43570 2/20 0.37
CA2 P00918 2/20 0.37
CA4 P22748 2/20 0.37
CA6 P23280 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37
CA14 Q9ULX7 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9316716 0.90 ALDH1A1 (0.43) THRBTP53KDM4ELMNAALDH1A1
SCHEMBL9315934 0.89 KDM4E (0.39) THRBTP53KDM4ELMNAALDH1A1
SCHEMBL9315814 0.89 TP53 (0.48) TAS1R3TAS1R1THRBTP53KDM4E
SCHEMBL9315905 0.89 CA12 (0.42) THRBTP53KDM4ELMNAALDH1A1
SCHEMBL9315029 0.88 KDM4E (0.40) THRBTP53KDM4ELMNAALDH1A1
SCHEMBL9315780 0.86 LMNA (0.39) THRBTP53KDM4ELMNAALDH1A1
SCHEMBL9315762 0.78 MAPT (0.35) KDM4ELMNAALDH1A1MAPT
SCHEMBL657972 0.76 THRB (0.45) TAS1R3TAS1R1THRBTP53KDM4E
SCHEMBL1269548 0.75 F10 (0.44) KDM4ELMNAALDH1A1MAPT
SCHEMBL482069 0.72 MAPT (0.46) KDM4ELMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed